Add BrightSurf on Google Email

Baylor College of Medicine


Early echocardiography to study pulmonary hypertension in mouse model of bronchopulmonary dysplasia

A new mouse model of bronchopulmonary dysplasia has been developed to study pulmonary hypertension, enabling the detection of the disease at an earlier time point through echocardiography tests. This breakthrough could lead to improved diagnoses and more effective treatments for premature infants.

SourceBaylor College of Medicine·JournalInternational Journal of Chronic Obstructive Pulmonary Disease·DateJul 15, 2016

New class of small molecule drug, SI-2, has potential for improving cancer treatment

Researchers at Baylor College of Medicine developed a new class of small molecule drug SI-2 that accelerates the destruction of cancer signaling molecule SRC-3, leading to slower cell proliferation and migration. The study suggests SI-2 has potential for improving cancer treatment with low toxicity to normal cells and animals.

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateApr 19, 2016

Evolution meets biochemistry to better understand how dopamine receptors work

Baylor College of Medicine researchers have developed a new mathematical tool that combines biochemistry and computational analysis to identify specific structural changes in the dopamine 2 receptor, which helps maintain its structure and function throughout an evolutionary time scale. This discovery opens the possibility for better dr...

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateMar 16, 2016

Understanding obesity from the inside out

Researchers developed a new laboratory method to study the function of GABA in brain processes controlling appetite and metabolism. The study found that mice lacking GABA in their hypothalamus, a key brain area regulating appetite, experienced significant weight loss and improved glucose tolerance.

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateMar 14, 2016

From chick to bedside: Removing the Wnt barrier

By disabling the Wnt signaling pathway, researchers may be able to repair damaged white matter in the brain, a potential breakthrough in treating cerebral palsy and multiple sclerosis. The study's findings suggest that targeting the Daam2/PIP5K interaction could accelerate oligodendrocyte differentiation and promote myelination.

SourceBaylor College of Medicine·JournalNeuron·DateMar 5, 2015